Percentage of bloodstream infection due to methicillin-resistant in Japan

Japan: Percentage of bloodstream infection due to methicillin-resistant was 33.9% in 2022. ▼ Falling

Latest (2022)
33.9%
Change on year
down 3.3%
World rank
16th
of 44 countries
All-time high
41.7%
in 2017
All-time low
33.9%
in 2022
Years of data
6
2017–2022

Percentage of bloodstream infection due to methicillin-resistant in Japan, 2017–2022

0102030402017201920222017: 41.72018: 40.62019: 36.42020: 35.92021: 35.12022: 33.9

Source: United Nations Statistics Division, SDG Global Database.

Analysis

The most recent figure for percentage of bloodstream infection due to methicillin-resistant in Japan is 33.9%, measured in 2022. That is the lowest value across all 6 years on record.

The figure is down 3.3% on the previous year and down 18.7% over ten years.

Japan ranks 16th of 44 countries on this measure, in the middle of the range.

Percentage of bloodstream infection due to methicillin-resistant in Japan, year by year

Annual values for Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%) in Japan, 2017 to 2022.
Year Value Change
2017 41.7%
2018 40.6% -2.6%
2019 36.4% -10.3%
2020 35.9% -1.5%
2021 35.1% -2.2%
2022 33.9% -3.3%

Averages by decade

DecadeAverage LowestHighest Years
2010s 39.6% 36.4% 41.7% 3
2020s 34.9% 33.9% 35.9% 3

Countries ranked near Japan

  1. 13 Greece 41.1% compare
  2. 14 United Arab Emirates 39.9% compare
  3. 15 Indonesia 35.2% compare
  4. 17 Argentina 32.8% compare
  5. 18 Italy 30.6% compare
  6. 19 Oman 28.6% compare

See the full ranking of 61 places →

More development goals data for Japan

All data for Japan →

Frequently asked questions

What is percentage of bloodstream infection due to methicillin-resistant in Japan?
Percentage of bloodstream infection due to methicillin-resistant in Japan was 33.9% in 2022, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to methicillin-resistant recorded in Japan?
The highest recorded value was 41.7% in 2017.
What is the lowest percentage of bloodstream infection due to methicillin-resistant recorded in Japan?
The lowest recorded value was 33.9% in 2022.
How does Japan rank for percentage of bloodstream infection due to methicillin-resistant?
Japan ranks 16th out of 44 countries with data for 2022.
Is percentage of bloodstream infection due to methicillin-resistant rising or falling in Japan?
Over the last ten years it is down 18.7%. The long-run trend across the full record is falling.
Where does this Japan data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to methicillin-resistant in Japan. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 01 September 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/japan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/japan/">Percentage of bloodstream infection due to methicillin-resistant in Japan</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
61 places, 372 data points, 2016–2022
Last refreshed